Chad vs Israel: Treatment success rate for patients treated for MDR-TB
Chad
73.0%
in 2022
Israel
73.0%
in 2022
Chad rank
83rd
Israel rank
83rd
Treatment success rate for patients treated for MDR-TB over time
- Chad
- Israel
How they compare
Chad currently reports 73.0% against 73.0% in Israel, a difference of 0.0%.
The two have swapped places 4 times across 9 shared years of data; in 2014 it was Israel ahead.
Chad ranks 83rd and Israel ranks 83rd of 163 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 54.5% | 68.8% | 14.3% | Israel |
| 2020s | 65.7% | 69.3% | 3.7% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chad or Israel?
- Chad, at 73.0% against 73.0% in Israel as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chad and Israel?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Israel?
- 9 years are reported by both, from 2014 to 2022.
- How do Chad and Israel rank globally for treatment success rate for patients treated for mdr-tb?
- Chad ranks 83rd and Israel ranks 83rd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.